NE7.5 Cognitive enhancers

Descrição

PHCY320 (Neurology) Quiz sobre NE7.5 Cognitive enhancers, criado por Mer Scott em 11-10-2019.
Mer Scott
Quiz por Mer Scott, atualizado more than 1 year ago
Mer Scott
Criado por Mer Scott aproximadamente 5 anos atrás
1
0

Resumo de Recurso

Questão 1

Questão
Age related changes to cognitive function: - Declining performance of: [blank_start]speed[blank_end] of processing, working memory, [blank_start]long[blank_end]-term memory - Preserved performance of: [blank_start]world knowledge[blank_end] Mild cognitive impairment affects 10-20% of people >[blank_start]65[blank_end] years, and affects [blank_start]men[blank_end] more than women. It is associated with [blank_start]depression[blank_end], polypharmacy, and uncontrolled [blank_start]CV[blank_end] risk factors.
Responda
  • speed
  • long
  • world knowledge
  • 65
  • men
  • depression
  • CV

Questão 2

Questão
Which of these is not a symptom of mild cognitive impairment? (MCI)
Responda
  • Diffiuclty in decision making
  • Poor concentration
  • Diffiuclty in abstract thinking
  • Difficulty in finding the right word
  • Neglect of hygiene and/or nutrition
  • More impulsive
  • Easily distracted
  • Forget important events
  • Mood fluctuations

Questão 3

Questão
Which of these is not a cognition enhancing drug?
Responda
  • Caffeine
  • Nicotine
  • Amphetamines
  • Cannabinoids

Questão 4

Questão
Treatment options are related to neurotransmitters in the brain regions controlling learning and memory, and temporarily improve dementia symptoms. [blank_start]Cholinesterase[blank_end] inhibitors: - E.g. donepezil, galantamine, rivastigmine • For [blank_start]mild[blank_end]-moderate cognitive symptoms • SEs: [blank_start]Nausea, vomiting, diarrhoea,[blank_end] dyspepsia; urinary incontinence; dizziness • Serious SEs: [blank_start]heart[blank_end] block and sinus [blank_start]bradycardia[blank_end] [blank_start]Glutamate antagonist[blank_end] ie Memantine • Moderate-[blank_start]severe[blank_end] cognitive symptoms OR when cholinesterase inhibitors [blank_start]contraindicated[blank_end] • SEs: c[blank_start]onstipation, hypertension, dyspnoea,[blank_end] headache, dizziness, drowsiness
Responda
  • Cholinesterase
  • Glutamate antagonist
  • mild
  • Nausea, vomiting, diarrhoea,
  • heart
  • bradycardia
  • severe
  • contraindicated
  • onstipation, hypertension, dyspnoea,

Questão 5

Questão
Nootropics or ‘smart drugs’: 1. [blank_start]Methylphenidate[blank_end] • Rx: narcoplepsy, ADHD, ADD • Blocks DA reuptake 2. [blank_start]Modafinil[blank_end] • Rx: narcolepsy • Mechanisms unclear (wake promoting neurons in tuberomammillary nucleus, DAT) 3. [blank_start]Piracetam[blank_end] • Rx: essential tremor (section 29) • Facilitates cholinergic, dopaminergic, noradrenergic neurotransmission Long term side effects are unclear. Short term: [blank_start]headache, dizziness, nausea[blank_end], [blank_start]psychiatric[blank_end] disorders, [blank_start]cardiovascular[blank_end] symptoms
Responda
  • Methylphenidate
  • Modafinil
  • Piracetam
  • psychiatric
  • headache, dizziness, nausea
  • cardiovascular

Semelhante

Neuro anatomy
James Murdoch
Neuro-Cognitive Disorders
SaraJaarour
Receptor Theory - L-type Calcium Channels
Anna mph
Neurology Final MCQs- 4th Year- PMU
Med Student
Hydrocephalus
Matthew Coulson
Pain and Some Neurological Disorders- Clinical Pharmacology 5th Year PMU
Med Student
Physiology of Vision
Matthew Coulson
Neuro Pharmacology - Depression and Anxiety
Ifeoma Okekearu
Neuroanatomy Lecture I
Matthew Coulson
Anatomy of the Peripheral Nervous System
Matthew Coulson
OSCE Cranial nerves 7-12
Ashutosh Kumar